[Asia Economy Reporter Ji Yeon-jin] Samsung Biologics reclaimed the 5th position in KOSPI market capitalization on the 12th, continuing its upward trend for the second consecutive day.
As of 9:42 AM on the day, Samsung Biologics was trading at 744,000 KRW, up 4.06% from the previous day. Its market capitalization reached 49.2267 trillion KRW, surpassing Hyundai Motor, which held the 5th position until the previous day with 49.1436 trillion KRW. Hyundai Motor was trading at 230,000 KRW, up 0.66% from the previous day.
Samsung Biologics had risen to 4th place in KOSPI market capitalization earlier this year with a market cap of 5.4 trillion KRW, but fell to 6th place recently due to a market correction starting at the end of January. After five consecutive days of decline earlier this month, it rose sharply by 4.38% the previous day following news of a large-scale US stimulus package approval, and continued its steep rise on the day.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
